Transcervical Foley catheter– endovenous oxytocin or oxytocin alone for induction of labor in term pregnancies

• Autores: Fuenmayor-Beltrán, Mariedg, Reyna-Villasmil, Eduardo, Santos-Bolívar, Joel, Mejía-Montilla, Jorly, Reyna-Villasmil, Nadia, Fernández-Ramírez, Andreina
• Formato: artículo
• Fecha de Publicación: 2017
• Institución: Sociedad Peruana de Obstetricia y Ginecología
• Repositorio: Revista SPOG - Revista Peruana de Ginecología y Obstetricia
• Lenguaje: español
• OAI Identifier: oai:ojs.spog:article/1985
• Enlace del recurso: http://www.spog.org.pe/web/revista/index.php/RPGO/article/view/1985
• Nivel de acceso: acceso abierto

Objective: To compare the effectiveness of transcervical Foley catheter – oxytocin with oxytocin alone for labor induction in term pregnancies. Design: Case-control study. Setting: Hospital Central “Dr. Urquinaona”, Maracaibo, Venezuela. Participants: Pregnant women undergoing cervical ripening and labor induction were randomly assigned to be treated with transcervical Foley catheter – oxytocin (group A) or oxytocin alone (group B). Main outcome measures: General characteristics, interval between beginning of induction and delivery, vaginal birth rate, maternal complications, perinatal variables, and adverse effects were evaluated. Results: There were no significant differences between groups in general characteristics (p = ns). Patients of group A showed a shorter interval between the beginning of induction and delivery compared with patients in group B (p < 0.05). There was no significant difference in vaginal birth rate between groups (p = ns). Newborns of both groups had similar mean values of Apgar scores at 1 minute and 5 minutes (p = ns). The most common adverse effect in both groups was nausea, but there were no significant differences between groups in frequency of adverse effects (p = ns). Conclusions: Use of transcervical Foley catheter – oxytocin shortened the interval between beginning of induction and delivery compared with oxytocin alone, with similar incidence of maternal and perinatal adverse effects.